HIV-1 promotes the degradation of components of the Type 1 IFN JAK/STAT 1 pathway and blocks antiviral ISG induction by Gargan, S, Ahmed, S, Mahony, R, Bannan, C, Napoletano, S, O'Farrelly, C, Borrow, P, Bergin, C, Stevenson, N

Impairment of CD8 T cell memory in DAA treated HCV/HIV co-infected patients by Hoffmann, M, Barnes, E, Abdou, M-T, Ring, S, Braun, DL, Flepp, M, Stoeckle, M, Conen, A, Beguelin, C, Schmid, P, Delaloye, J, Nguyen, A, Bernasconi, E, Bannan, C, Dorrell, L, Rauch, A, Boeni, J, Fehr, JS, Flatz, L

A novel vaccine strategy employing serologically different chimpanzee adenoviral vectors for the prevention of HIV-1 and HCV coinfection by Hartnell, F, Brown, A, Capone, S, Kopycinski, J, Bliss, C, Makvandi-Nejad, S, Swadling, L, Ghaffari, E, Cicconi, P, Del Sorbo, M, Sbrocchi, R, Esposito, I, Vassilev, V, Marriott, P, Gardiner, C, Bannan, C, Bergin, C, Hoffmann, M, Turner, B, Nicosia, A, Folgori, A, Hanke, T, Barnes, E, Dorrell, L, PEACHI Consortium